Welcome! 
At MSD Denmark, a subsidiary of Merck & Co. Inc., located in Whitehouse Station, NJ, we are strongly committed to partnership success. We recognize that the greatest achievements are not reached alone. They are the result of teamwork.

The philosophy of great achievements through teamwork is not new to us. We have a long tradition of successful partnerships. Alliances with innovative partners are an integral and essential part of our long-term business and research strategy. Our goal is for our partners and us to work together to accelerate the successful development and commercialization of breakthrough products that can bring meaningful improvements to patients’ lives.

We understand that you have unique strengths to identify innovative therapeutic approaches. We are seeking partners with high quality science and subject matter and most important the enthusiasm to collaborate with us and share a vision to bring the best medicine to patients worldwide.

Mervyn Turner, Ph.D.
Chief Strategy Officer, Merck & Co., Inc., and
Senior Vice President, Worldwide Licensing and External Research
Merck Research Laboratories.

" Licensing and collaborative research form a vital part of our mission to bring to the market new medicines that improve the health and well being of patients. We are committed to collaborations with biotech companies and academic institutions as a key way of expanding our internal strength in discovery and development. We encourage you to contact our European Licensing and External Research group to explore how we might work together to reinforce our joint commitment to producing better medicines for patients the world over."

Stefan Oschmann
President Human Health-EMEA & Canada
Europe, Middle East, Africa and Canada